In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ev3, FoxHollow sign peripheral artery disease alliance

Executive Summary

Ev3 (catheter-based devices for cardiovascular diseases) and FoxHollow Technologies (minimally invasive devices to remove plaque and thrombus) have teamed up to jointly study the former's SpideRx embolic protection devices with the latter's RockHawk calcium cutting device as a treatment for calcified lesions in patients with peripheral artery disease.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies